KAMN vs. AMAM
Compare and contrast key facts about Kaman Corporation (KAMN) and Ambrx Biopharma Inc. (AMAM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KAMN or AMAM.
Key characteristics
| KAMN | AMAM |
|---|
Fundamentals
| KAMN | AMAM | |
|---|---|---|
| Market Cap | $1.31B | $1.77B |
| EPS | $0.28 | $0.42 |
| PE Ratio | 164.25 | 66.67 |
| Revenue (TTM) | $775.85M | $4.09M |
| Gross Profit (TTM) | $226.59M | $7.40M |
| EBITDA (TTM) | $105.36M | -$61.75M |
Correlation
The correlation between KAMN and AMAM is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KAMN vs. AMAM - Performance Comparison
The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KAMN vs. AMAM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Kaman Corporation (KAMN) and Ambrx Biopharma Inc. (AMAM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KAMN vs. AMAM - Dividend Comparison
KAMN's dividend yield for the trailing twelve months is around 1.74%, while AMAM has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KAMN Kaman Corporation | 1.74% | 3.34% | 3.59% | 1.85% | 1.40% | 1.21% | 1.43% | 1.36% | 1.47% | 1.76% | 1.60% | 1.61% |
AMAM Ambrx Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
KAMN vs. AMAM - Drawdown Comparison
Volatility
KAMN vs. AMAM - Volatility Comparison
Kaman Corporation (KAMN) has a higher volatility of 0.41% compared to Ambrx Biopharma Inc. (AMAM) at 0.00%. This indicates that KAMN's price experiences larger fluctuations and is considered to be riskier than AMAM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
KAMN vs. AMAM - Financials Comparison
This section allows you to compare key financial metrics between Kaman Corporation and Ambrx Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities